Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE Vernova Inc (GEV) vs Mesoblast Limited (MESO) Price & Performance

GE Vernova IncTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Mesoblast Limited — how do they compare? GE Vernova Inc trades at $1,043.73 (market cap $269.50B), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: GE Vernova Inc is far larger — about 121.9× Mesoblast Limited's market cap, and GE Vernova Inc pays a 0.2% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

GEVMESO
Market Cap
$269.50B$2.21B
Sector
TechnologyTechnology
52-Week High
$1.17K$20.96
52-Week Low
$547.96$12.88
Enterprise Value
$259.17B$2.21B
Dividend Yield
0.2%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO